|
An Independent Consultant, Mr. Stoughton's background includes almost three decades in senior management positions in health care services and diagnostics, including moving proprietary diagnostic tests to market, brings to Biomira his extensive experience as well as his knowledge of the pharmaceutical industry where he was a member of the senior executive management team of Smith Kline Beecham. Mr. Stoughton’s career includes 10 years as President and CEO of Toronto General Hospital, the largest teaching hospital in Canada, and of its successor, Toronto Hospital. Mr. Stoughton also served as CEO of Peter Bent Brigham Hospital, affiliated with Harvard University and CEO of Duke University Medical Center. He was also the first Chief Operating Officer of the Brigham and Women’s Hospital. Mr. Stoughton was President of Smith Kline Beecham Diagnostics and President of Smith Kline Beecham Clinical Labs, where he was responsible for increasing sales from $960 million to $1.3 billion. Most recently he was founder, Chairman and CEO of Careside, Inc., a research, development, and medical devices company.
Mr. Stoughton has been on the Board of Directors since June 1997.
| 